Smith & Nephew plc (LON:SN) Given Average Recommendation of “Hold” by Brokerages

Smith & Nephew plc (LON:SN) has been given an average recommendation of “Hold” by the eight ratings firms that are covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is GBX 1,382.63.

SN has been the subject of a number of research analyst reports. Royal Bank Of Canada cut shares of Smith & Nephew to a “sector perform” rating and set a GBX 1,350 price target for the company. in a report on Thursday, May 7th. UBS Group reissued a “neutral” rating and set a GBX 1,300 target price on shares of Smith & Nephew in a report on Tuesday, May 5th. Jefferies Financial Group reissued a “buy” rating and set a GBX 2,760 target price on shares of Smith & Nephew in a report on Thursday, May 21st. Finally, Berenberg Bank reissued a “hold” rating and set a GBX 13 target price on shares of Smith & Nephew in a report on Friday, May 1st.

Smith & Nephew Trading Up 1.3%

LON SN opened at GBX 1,147 on Monday. The business has a 50-day moving average of GBX 1,165.29 and a two-hundred day moving average of GBX 1,223.26. The stock has a market capitalization of £12.57 billion, a PE ratio of 41.30, a P/E/G ratio of 0.46 and a beta of 0.67. The company has a current ratio of 2.57, a quick ratio of 0.84 and a debt-to-equity ratio of 62.90.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.